Kraj: Nowa Zelandia
Język: angielski
Źródło: Medsafe (Medicines Safety Authority)
Diazepam 2mg
Teva Pharma (New Zealand) Limited
Diazepam 2 mg
2 mg
Tablet
Active: Diazepam 2mg Excipient: Lactose Magnesium stearate Maize starch Purified water
Blister pack, PVC/Al 50 dose units, 50 tablets
Class C5 Controlled Drug
Class C5 Controlled Drug
F.I.S. Fabbrica Italiana Sintetici SpA
Adults: Short term (2-4 weeks) symptomatic treatment of anxiety that is severe, disabling or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic or psychotic illness. Short term (2-4 weeks) treatment of conditions where anxiety may be a precipitating or aggravating factor e.g. tension headaches or migraine attack. Symptomatic treatment of acute alcohol withdrawal. Muscle spasm. As an adjunct to the control of muscle spasm in tetanus. May be useful in the management of cerebral spasticity in selected cases. As a adjunct to the management of some types of epilepsy, e.g. myoclonus. Premedication. Children: Night terrors and somnambulism. May be useful in controlling tension and irritability in cerebral spasticity in selected cases. As an adjunct to the control of muscle spasm in tetanus. Premedication.
Package - Contents - Shelf Life: Blister pack, PVC/Al 50 dose units - 50 tablets - 36 months from date of manufacture stored at or below 30°C protect from light - Bottle, plastic, HDPE with PP screw cap 200 tablets - 200 tablets - 36 months from date of manufacture stored at or below 30°C protect from light - Bottle, plastic, HDPE with HDPE cap with tamper evident ring - 500 tablets - 36 months from date of manufacture stored at or below 30°C protect from light - Bottle, plastic, HDPE with PP/HDPE child resistant cap & Al seal, 500 tablets - 500 tablets - 36 months from date of manufacture stored at or below 30°C protect from light - Bottle, plastic, HDPE with PP screw cap 500 tablets - 500 tablets - 36 months from date of manufacture stored at or below 30°C protect from light
2009-01-23
NEW ZEALAND CONSUMER MEDICINE INFORMATION ARROW - DIAZEPAM Diazepam 2mg and 5mg tablets WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ARROW - DIAZEPAM. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking ARROW - DIAZEPAM against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. YOU MAY NEED TO READ IT AGAIN. WHAT ARROW - DIAZEPAM IS USED FOR ARROW - DIAZEPAM contains diazepam. It belongs to a group of medicines called benzodiazepines. These medicines are thought to work by their actions on brain chemicals. ARROW - DIAZEPAM is a sedative, muscle relaxant and anticonvulsant, used for the following conditions: • severe anxiety, occurring alone or related to insomnia or mental illness • tension headaches and migraine attacks where anxiety is the cause or aggravating factor • symptoms of alcohol withdrawal, such as trembling, confusion or anxiety • muscle spasm, including spasms of tetanus or cerebral spasticity (selected cases) • some types of epilepsy • premedication • night terrors and sleep-walking, especially in children. Like other benzodiazepines, ARROW - DIAZEPAM is not recommended as the sole treatment of severe mental illnesses and should not be used alone to treat depression. Your doctor may have prescribed ARROW - DIAZEPAM for another reason. Ask your doctor if you have any questions about why ARROW - DIAZEPAM has been prescribed for you. ARROW - DIAZEPAM is not recommended in children less than 6 months old. In general, benzodiazepines should be taken for short periods only (around 2 to 4 weeks). Continuous long-term use is not recommended unless advised by your doctor. THE USE OF BENZODIAZEPINES MAY LEAD TO DEPENDENCE OF THE MEDICINE. ARROW - DIAZEPAM is available only with a doctor's pres Przeczytaj cały dokument
Version 2.0 1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME Arrow – Diazepam 2, tablets, 2 mg Arrow – Diazepam 5, tablets, 5 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 2 mg or 5 mg of diazepam. Excipient with known effect: lactose For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Arrow - Diazepam 2: White, round, flat-bevel edged tablet embossed with ‘D2’ on one side and breakline on the other side. Each tablet contains diazepam 2 mg. Arrow - Diazepam 5: Yellow, round, flat-bevel edged tablet embossed with ‘D5’ on one side and breakline on the other side. Each tablet contains diazepam 5 mg. The tablet can be divided into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Adults_ Short-term (2 to 4 weeks) symptomatic treatment of anxiety that is severe, disabling or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short-term psychosomatic, organic or psychotic illness. Short-term (2 to 4 weeks) treatment of conditions where anxiety may be a precipitating or aggravating factor, e.g. tension headaches or migraine attacks. Symptomatic treatment of acute alcohol withdrawal. Muscle spasm. As an adjunct to the control of muscle spasm in tetanus. May be useful in the management of cerebral spasticity in selected cases. As an adjunct to the management of some types of epilepsy, e.g. myoclonus. Premedication. _Children_ Night terrors and somnambulism. May be useful in controlling tension and irritability in cerebral spasticity in selected cases. As an adjunct to the control of muscle spasm in tetanus. Premedication. 4.2 DOSE AND METHOD OF ADMINISTRATION This product may not be interchangeable with other products containing this ingredient in the New Zealand's market. Version 2.0 2 ANXIETY STATES Adults: Usual dose: 2 mg three times daily. Maximum dose: Up to 30 mg daily in divided doses. Adjusted on an individual basis. Insomnia associated with anxiety: 5 to 15 mg before retiring. The lowest dose which Przeczytaj cały dokument